Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CFTR in alveolar type 1 cells contributes to lung liquid secretion and host defense
Sayahi Suthakaran, Sonya Homami, Deebly Chavez, Stephanie Tang, Sarah K.L. Moore, Chaya Sussman, Jimmy Zhang, Clemente J. Britto, Alice Prince, Alison J. May, Jaymin J. Kathiriya, Jaime L. Hook
Sayahi Suthakaran, Sonya Homami, Deebly Chavez, Stephanie Tang, Sarah K.L. Moore, Chaya Sussman, Jimmy Zhang, Clemente J. Britto, Alice Prince, Alison J. May, Jaymin J. Kathiriya, Jaime L. Hook
View: Text | PDF
Research Article Cell biology Infectious disease Pulmonology

CFTR in alveolar type 1 cells contributes to lung liquid secretion and host defense

  • Text
  • PDF
Abstract

CFTR in the lung epithelium contributes to the secretion of a surface liquid layer that is essential to lung homeostasis and defense. The understanding of how liquid is secreted in the lung is derived largely from studies of the airway epithelium. Comparatively little is known about liquid secretion mechanisms in the alveolar epithelium, including its cellular source. To define which cell type drives alveolar liquid secretion, we generated transgenic mice that expressed a Cftr-null allele in alveolar type 1 (AT1) cells, type 2 (AT2) cells, or both, then viewed liquid secretion in live alveoli using confocal microscopy of isolated, perfused lungs. Our findings show that liquid secretion was blocked in alveoli of all 3 transgenic mice, indicating that both AT1 and AT2 cells contribute to alveolar liquid secretion. Cftr-null expression in AT1 cells also blocked the secretion-mediated clearance of small particle and bacterial clusters from alveolar walls, indicating that AT1 cell CFTR contributes to alveolar defense. Together, these findings show alveolar liquid secretion depends on both AT1 and AT2 cell CFTR, and that CFTR in AT1 cells — a cell type not traditionally considered in liquid secretion mechanisms or CFTR-related lung diseases — contributes to lung liquid dynamics and host defense.

Authors

Sayahi Suthakaran, Sonya Homami, Deebly Chavez, Stephanie Tang, Sarah K.L. Moore, Chaya Sussman, Jimmy Zhang, Clemente J. Britto, Alice Prince, Alison J. May, Jaymin J. Kathiriya, Jaime L. Hook

×

Figure 3

Real-time confocal imaging of liquid secretion in live alveoli.

Options: View larger image (or click on image) Download as PowerPoint
Real-time confocal imaging of liquid secretion in live alveoli.
(A–G) Il...
(A–G) Illustration in A shows the design of confocal imaging studies of liquid transport in live alveoli of intact, perfused lungs of transgenic mice of the genotypes indicated in B–G. As indicated in A, we microinstilled alveolar airspaces with Alexa Fluor 647–conjugated dextran (AF-dextran, yellow, 10 kDa, 10 mg/mL) to carry out the determinations of liquid transport shown in B–F. At the conclusion of each experiment, we added fluorescein isothiocyanate-conjugated dextran (FITC-dextran, cyan, 20 kDa, 5 mg/mL) to the lung perfusate solution to define alveolar barrier properties. The confocal image in B shows AF-dextran fluorescence in airspaces of alveoli (magenta) of a TdTomato-expressing LMC-TdTomato mouse at 2 minutes after AF-dextran microinstillation. Air, example airspace. Arrowheads point out example AF-dextran pools at alveolar niches. Images and group data in C and D show change of AF-dextran fluorescence over time. Fluorescence of alveolar walls is not shown. In D, circles indicate n and each represent one mouse in which mean fluorescence change was quantified in imaging fields of at least 30 alveoli; data are shown as mean ± SEM; *P < 0.05 by ANOVA with post hoc Tukey testing. High power views in E show widths of the example AF-dextran pool (white dashed lines and text) and airspace (magenta dashed lines and text) indicated by the dashed square in B. Group data in F show pool and airspace widths over time. In F, circles and bars are as in D; P is as indicated by 2-tailed t test. The confocal image in G shows fluorescence of FITC-dextran added to the lung perfusate solution. Images in B and G represent images generated in 3 mice each of LMC-TdTomato, AT2-AT1-CFTRnull-GFP, AT2-CFTRnull-GFP, and AT1-CFTRnull-GFP mouse groups. Scale bars: 100 (B and G), 50 (C), 20 (E) μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts